ArticleCureus2025
Acute Necrotizing Encephalopathy in a Child With RANBP2 Mutation: A Case of Unanticipated Full Resolution.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Decoding the lung-brain axis in influenza: from pulmonary infection to central nervous system injury.Journal of neuroinflammation · 2026Review
- Pathogenesis and Research Models of Acute Influenza-Associated Encephalitis/Encephalopathy: An Update.Viruses · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute necrotizing encephalopathy (ANE) is a rare, rapidly progressive pediatric encephalopathy, often triggered by viral infections such as influenza A (H1N1), and typically characterized by bilateral thalamic involvement with high morbidity and mortality. We present a case of a previously healthy two-year-old girl who developed fever and respiratory symptoms, followed by sudden neurological deterioration and shock. Initial investigations revealed markedly elevated liver enzymes with normal cerebrospinal fluid analysis. Nasopharyngeal swabs tested positive for H1N1. Brain magnetic resonance imaging (MRI) revealed symmetric lesions involving the thalami and brainstem. Genetic analysis identified a heterozygous pathogenic mutation in the RANBP2 gene. Based on the clinical presentation, virologic findings, and characteristic imaging features, a diagnosis of ANE was established. The patient was promptly treated with intravenous immunoglobulin and high-dose corticosteroids, resulting in full neurological recovery within six weeks. This case underscores the importance of the early recognition and diagnosis of ANE and highlights the potential for favorable outcomes with timely immunotherapy, even in the presence of a RANBP2 mutation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.